HDAC9 and malignant colon neoplasm: Recent research has further elucidated that HDAC inhibitors can impede colon cancer progression or metastasis by modulating various cellular processes, including mitosis63, adhesion64, apoptosis, epithelial-mesenchymal transition65, and drug resistance66 in mesenchymal tumor cells.